Why the study?
Does oral dipyridamole therapy improve symptoms and prevent ventricular arrhythmias in patients with coronary slow flow phenomenon?
Population
1 patient with coronary slow flow phenomenon presenting with anginal chest pain and recurrent syncope…
Design
Case_report
Follow-up
3 months
Authors
Loading...
Should not change practice in coronary slow flow; this case leaves open the need for controlled trials.
Does oral dipyridamole therapy improve symptoms and prevent ventricular arrhythmias in patients with coronary slow flow phenomenon?
Oral dipyridamole therapy may be effective in resolving symptoms and suppressing ventricular arrhythmias in patients with coronary slow flow phenomenon.
Saya et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: